Surgical Innovations Group Plc’s Buy Rating Reaffirmed at Panmure Gordon (SUN)
Surgical Innovations Group Plc (LON:SUN)‘s stock had its “buy” rating restated by equities research analysts at Panmure Gordon in a research note issued to investors on Friday, AnalystRatingsNetwork reports. They currently have a GBX 7.60 ($0.12) price target on the stock. Panmure Gordon’s target price would indicate a potential upside of 29.03% from the company’s current price.
Surgical Innovations Group Plc (LON:SUN) traded down 3.83% on Friday, hitting GBX 5.65. The stock had a trading volume of 130,205 shares. Surgical Innovations Group Plc has a one year low of GBX 4.25 and a one year high of GBX 7.80. The stock has a 50-day moving average of GBX 5.84 and a 200-day moving average of GBX 5.43.
Separately, analysts at Beaufort Securities initiated coverage on shares of Surgical Innovations Group Plc (LON:SUN) in a research note to investors on Wednesday, September 11th. They set a “speculative buy” rating on the stock.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.